Do Expert Agencies Outperform Generalist Judges?
Empirical evidence suggests that expert agencies perform no better than courts.
Patents, Patients, and Profits: Winners and Losers in Drug Patent Challenges
Challenges to branded drugs from generic firms have benefits and costs.
Appreciating the Politics Inside Benefit-Cost Analysis
Empirical research reveals stronger benefit-cost analysis during less political rulemakings.
Administration Articulates Only Fine Distinctions in Defending Health Care Reform
Solicitor General limits his Supreme Court arguments to the specifics of health insurance.
Comparing the Presidential Candidates’ Energy Policies
Obama and his Republican rivals seek different paths to energy independence.
Beyond Cost-Benefit Analysis
Social welfare function incorporates distributional considerations into policy analysis.
Environmental Regulation Should Not Distort Competition
Policy makers must consider how environmental regulation affects markets.
Reconciling Cost-Benefit Analysis with the Precautionary Principle
CBA methodology can respond to societal risk-aversion.
Santorum’s Views on Regulation
Republican presidential candidate says he would revoke “irrational” regulation.
Regulatory Conference Discusses Oversight of Laboratory Developed Tests
Regulatory conference highlights need for defined governance of laboratory developed diagnostic testing.
Mitt Romney’s Ideas about Environmental and Energy Policy
Republican front-runner proposes reining in regulation while increasing production of domestic energy sources.
Randomizing Regulation
Governments can best determine the efficacy of regulations through randomized trials.